Do analysts recommend LUCYW or NXGL?

NexGel has a consensus price target of $2.00, suggesting a potential upside of 898.50%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NexGel 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Which has preferable valuation and earnings, LUCYW or NXGL?

Innovative Eyewear has higher earnings, but lower revenue than NexGel. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Innovative Eyewear $3.41M N/A N/A N/A N/A NexGel $12.07M 0.16 -$3M -$0.71 N/A

Do analysts prefer NXGLW or NXGL?

NexGel has a consensus price target of $2.00, suggesting a potential upside of 898.50%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than NEXGEL. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NexGel 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Which has higher valuation & earnings, NXGLW or NXGL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NEXGEL $12.07M N/A N/A N/A N/A NexGel $12.07M 0.16 -$3M -$0.71 N/A

Is NXGLW or NXGL more profitable?

NEXGEL has a net margin of 0.00% compared to NexGel's net margin of -51.26%. NEXGEL's return on equity of 0.00% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NEXGEL N/A N/A N/A NexGel -51.26% -121.18% -41.15%

Do analysts rate WOK or NXGL?

NexGel has a consensus price target of $2.00, indicating a potential upside of 898.50%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than WORK Medical Technology Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WORK Medical Technology Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NexGel 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Which has preferable earnings and valuation, WOK or NXGL?

WORK Medical Technology Group has higher earnings, but lower revenue than NexGel. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WORK Medical Technology Group $10.72M N/A -$1.07M N/A N/A NexGel $12.07M 0.16 -$3M -$0.71 N/A

Does the media favor WOK or NXGL?

In the previous week, NexGel had 8 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 10 mentions for NexGel and 2 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 0.75 beat NexGel's score of 0.32 indicating that WORK Medical Technology Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment WORK Medical Technology Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NexGel 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, MDLN or NXGL?

Medline has higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medline $28.43B 1.68 $1.16B $0.79 45.90 NexGel $12.07M 0.16 -$3M -$0.71 N/A

Is MDLN or NXGL more profitable?

Medline has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Medline's return on equity of 0.00% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets Medline N/A N/A N/A NexGel -51.26% -121.18% -41.15%

Does the media prefer MDLN or NXGL?

In the previous week, Medline had 10 more articles in the media than NexGel. MarketBeat recorded 20 mentions for Medline and 10 mentions for NexGel. NexGel's average media sentiment score of 0.32 beat Medline's score of 0.15 indicating that NexGel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medline 7 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, ALC or NXGL?

Alcon has higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.05 $980M $1.31 48.90 NexGel $12.07M 0.16 -$3M -$0.71 N/A

Is ALC or NXGL more profitable?

Alcon has a net margin of 5.92% compared to NexGel's net margin of -51.26%. Alcon's return on equity of 7.29% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets Alcon 5.92% 7.29% 5.09% NexGel -51.26% -121.18% -41.15%

Does the media favor ALC or NXGL?

In the previous week, NexGel had 5 more articles in the media than Alcon. MarketBeat recorded 10 mentions for NexGel and 5 mentions for Alcon. NexGel's average media sentiment score of 0.32 beat Alcon's score of 0.28 indicating that NexGel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

NexGel (NXGL) Competitors

$0.20 +0.05 (+33.53%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.17 -0.03 (-13.13%)

As of 10/9/2026 07:49 PM Eastern

Compare

NXGL vs. LUCYW, NXGLW, WOK, MDLN, and ALC

Should you buy NexGel stock or one of its competitors? NexGel's main competitors and comparable companies include Innovative Eyewear (LUCYW), NEXGEL (NXGLW), WORK Medical Technology Group (WOK), Medline (MDLN), and Alcon (ALC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does NexGel compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Innovative Eyewear has higher earnings, but lower revenue than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A
NexGel	$12.07M	0.16	-$3M	-$0.71	N/A

Innovative Eyewear has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Innovative Eyewear's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	N/A	N/A	N/A
NexGel	-51.26%	-121.18%	-41.15%

2.2% of NexGel shares are owned by institutional investors. 19.8% of NexGel shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

NexGel has a consensus price target of $2.00, suggesting a potential upside of 898.50%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NexGel	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, NexGel had 8 more articles in the media than Innovative Eyewear. MarketBeat recorded 10 mentions for NexGel and 2 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.80 beat NexGel's score of 0.32 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company	Overall Sentiment
Innovative Eyewear	Positive
NexGel	Neutral

Summary

NexGel beats Innovative Eyewear on 6 of the 10 factors compared between the two stocks.

How does NexGel compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

NEXGEL has a net margin of 0.00% compared to NexGel's net margin of -51.26%. NEXGEL's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NEXGEL	N/A	N/A	N/A
NexGel	-51.26%	-121.18%	-41.15%

In the previous week, NexGel had 9 more articles in the media than NEXGEL. MarketBeat recorded 10 mentions for NexGel and 1 mentions for NEXGEL. NexGel's average media sentiment score of 0.32 beat NEXGEL's score of 0.00 indicating that NexGel is being referred to more favorably in the news media.

Company	Overall Sentiment
NEXGEL	Neutral
NexGel	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NEXGEL	$12.07M	N/A	N/A	N/A	N/A
NexGel	$12.07M	0.16	-$3M	-$0.71	N/A

2.2% of NexGel shares are owned by institutional investors. 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

NexGel has a consensus price target of $2.00, suggesting a potential upside of 898.50%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than NEXGEL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NEXGEL	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NexGel	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

NexGel beats NEXGEL on 6 of the 9 factors compared between the two stocks.

How does NexGel compare to WORK Medical Technology Group?

WORK Medical Technology Group (NASDAQ:WOK) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

WORK Medical Technology Group has higher earnings, but lower revenue than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$10.72M	N/A	-$1.07M	N/A	N/A
NexGel	$12.07M	0.16	-$3M	-$0.71	N/A

NexGel has a consensus price target of $2.00, indicating a potential upside of 898.50%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than WORK Medical Technology Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

2.2% of NexGel shares are held by institutional investors. 19.8% of NexGel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

WORK Medical Technology Group has a beta of 1.75, meaning that its share price is 75% more volatile than the broader market. Comparatively, NexGel has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

WORK Medical Technology Group has a net margin of 0.00% compared to NexGel's net margin of -51.26%. WORK Medical Technology Group's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
NexGel	-51.26%	-121.18%	-41.15%

In the previous week, NexGel had 8 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 10 mentions for NexGel and 2 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 0.75 beat NexGel's score of 0.32 indicating that WORK Medical Technology Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WORK Medical Technology Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

WORK Medical Technology Group and NexGel tied by winning 6 of the 12 factors compared between the two stocks.

How does NexGel compare to Medline?

Medline (NASDAQ:MDLN) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Medline has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Medline's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
NexGel	-51.26%	-121.18%	-41.15%

In the previous week, Medline had 10 more articles in the media than NexGel. MarketBeat recorded 20 mentions for Medline and 10 mentions for NexGel. NexGel's average media sentiment score of 0.32 beat Medline's score of 0.15 indicating that NexGel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	7 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Medline presently has a consensus target price of $46.81, suggesting a potential upside of 29.09%. NexGel has a consensus target price of $2.00, suggesting a potential upside of 898.50%. Given NexGel's higher possible upside, analysts plainly believe NexGel is more favorable than Medline.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83
NexGel	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Medline has higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.68	$1.16B	$0.79	45.90
NexGel	$12.07M	0.16	-$3M	-$0.71	N/A

2.2% of NexGel shares are owned by institutional investors. 0.8% of Medline shares are owned by company insiders. Comparatively, 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Medline beats NexGel on 12 of the 16 factors compared between the two stocks.

How does NexGel compare to Alcon?

Alcon (NYSE:ALC) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Alcon has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, NexGel has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

53.9% of Alcon shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 1.5% of Alcon shares are owned by company insiders. Comparatively, 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Alcon has a net margin of 5.92% compared to NexGel's net margin of -51.26%. Alcon's return on equity of 7.29% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	5.92%	7.29%	5.09%
NexGel	-51.26%	-121.18%	-41.15%

Alcon presently has a consensus target price of $84.43, indicating a potential upside of 31.80%. NexGel has a consensus target price of $2.00, indicating a potential upside of 898.50%. Given NexGel's higher possible upside, analysts clearly believe NexGel is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
NexGel	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, NexGel had 5 more articles in the media than Alcon. MarketBeat recorded 10 mentions for NexGel and 5 mentions for Alcon. NexGel's average media sentiment score of 0.32 beat Alcon's score of 0.28 indicating that NexGel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alcon has higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.05	$980M	$1.31	48.90
NexGel	$12.07M	0.16	-$3M	-$0.71	N/A

Summary

Alcon beats NexGel on 13 of the 17 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NXGL vs. The Competition

Export

Metric	NexGel	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.46M	$5.43B	$7.16B	$13.21B
Dividend Yield	N/A	1.77%	2.53%	16.37%
P/E Ratio	-0.28	25.57	275.30	26.16
Price / Sales	0.16	83.34	635.97	107.53
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	0.33	5.95	11.22	6.33
Net Income	-$3M	$146.18M	$3.50B	$382.15M
7 Day Performance	15.11%	-0.28%	-0.89%	-1.40%
1 Month Performance	-30.95%	-1.88%	-4.42%	-3.47%
1 Year Performance	-92.21%	5.45%	7.03%	1.18%

NexGel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NXGL NexGel	2.6599 of 5 stars	$0.20 +33.5%	$2.00 +898.5%	-92.5%	$1.46M	$12.07M	N/A	19	Short Interest Increase Gap Up High Trading Volume
LUCYW Innovative Eyewear	N/A	$0.03 -20.2%	N/A	-71.5%	$0.00	$3.41M	N/A	13	News Coverage Positive News Short Interest Increase Gap Down High Trading Volume
NXGLW NEXGEL	N/A	$0.01 +13.9%	N/A	-96.3%	$0.00	$12.07M	N/A	19	Positive News
WOK WORK Medical Technology Group	N/A	$1.77 -2.2%	N/A	-100.0%	$0.00	$9.81M	N/A	238	Positive News
MDLN Medline	3.0888 of 5 stars	$34.71 -0.8%	$46.88 +35.1%	N/A	$45.99B	$28.43B	43.94	45,000	Analyst Downgrade Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NXGL) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NexGel (NXGL) Competitors

NXGL vs. LUCYW, NXGLW, WOK, MDLN, and ALC

How does NexGel compare to Innovative Eyewear?

Summary

How does NexGel compare to NEXGEL?

Summary

How does NexGel compare to WORK Medical Technology Group?

Summary

How does NexGel compare to Medline?

Summary

How does NexGel compare to Alcon?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NexGel (NXGL) Competitors

NXGL vs. LUCYW, NXGLW, WOK, MDLN, and ALC

How does NexGel compare to Innovative Eyewear?

Which has preferable valuation and earnings, LUCYW or NXGL?

Is LUCYW or NXGL more profitable?

Do institutionals & insiders hold more shares of LUCYW or NXGL?

Do analysts recommend LUCYW or NXGL?

Does the media favor LUCYW or NXGL?

Summary

How does NexGel compare to NEXGEL?

Is NXGLW or NXGL more profitable?

Does the media prefer NXGLW or NXGL?

Which has higher valuation & earnings, NXGLW or NXGL?

Do insiders and institutionals hold more shares of NXGLW or NXGL?

Do analysts prefer NXGLW or NXGL?

Summary

How does NexGel compare to WORK Medical Technology Group?

Which has preferable earnings and valuation, WOK or NXGL?

Do analysts rate WOK or NXGL?

Do insiders & institutionals believe in WOK or NXGL?

Which has more risk and volatility, WOK or NXGL?

Is WOK or NXGL more profitable?

Does the media favor WOK or NXGL?

Summary

How does NexGel compare to Medline?

Is MDLN or NXGL more profitable?

Does the media prefer MDLN or NXGL?

Do analysts rate MDLN or NXGL?

Which has preferable valuation & earnings, MDLN or NXGL?

Do institutionals & insiders have more ownership in MDLN or NXGL?

Summary

How does NexGel compare to Alcon?

Which has more risk and volatility, ALC or NXGL?

Do institutionals and insiders hold more shares of ALC or NXGL?

Is ALC or NXGL more profitable?

Do analysts rate ALC or NXGL?

Does the media favor ALC or NXGL?

Which has better earnings & valuation, ALC or NXGL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools